Mutual Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Buy |
+7,708
| New | +$200K | 0.01% | 1131 |
|
|
2025
Q1 | – | Sell |
-38,376
| Closed | -$931K | – | 1084 |
|
|
2024
Q4 | $931K | Sell |
38,376
-2,084
| -5% | -$50.5K | 0.03% | 500 |
|
|
2024
Q3 | $942K | Sell |
40,460
-763
| -2% | -$17.8K | 0.03% | 498 |
|
|
2024
Q2 | $1.11M | Sell |
41,223
-948
| -2% | -$25.5K | 0.03% | 452 |
|
|
2024
Q1 | $1.21M | Sell |
42,171
-618
| -1% | -$17.8K | 0.04% | 422 |
|
|
2023
Q4 | $1.4M | Sell |
42,789
-865
| -2% | -$28.4K | 0.05% | 355 |
|
|
2023
Q3 | $1.22M | Buy |
43,654
+1,257
| +3% | +$35K | 0.05% | 369 |
|
|
2023
Q2 | $1.45M | Buy |
42,397
+361
| +0.9% | +$12.3K | 0.05% | 332 |
|
|
2023
Q1 | $1.26M | Buy |
42,036
+820
| +2% | +$24.7K | 0.05% | 356 |
|
|
2022
Q4 | $1.16M | Sell |
41,216
-7,301
| -15% | -$206K | 0.05% | 371 |
|
|
2022
Q3 | $1.6M | Buy |
48,517
+137
| +0.3% | +$4.5K | 0.08% | 239 |
|
|
2022
Q2 | $1.52M | Sell |
48,380
-3,090
| -6% | -$97.3K | 0.1% | 237 |
|
|
2022
Q1 | $2.36M | Buy |
51,470
+3,775
| +8% | +$173K | 0.13% | 181 |
|
|
2021
Q4 | $2.92M | Buy |
47,695
+7,531
| +19% | +$461K | 0.15% | 155 |
|
|
2021
Q3 | $3M | Buy |
40,164
+4,563
| +13% | +$341K | 0.18% | 139 |
|
|
2021
Q2 | $3.29M | Buy |
35,601
+14,908
| +72% | +$1.38M | 0.2% | 130 |
|
|
2021
Q1 | $1.84M | Sell |
20,693
-2,375
| -10% | -$211K | 0.13% | 205 |
|
|
2020
Q4 | $2.15M | Buy |
23,068
+1,341
| +6% | +$125K | 0.16% | 148 |
|
|
2020
Q3 | $1.38M | Buy |
+21,727
| New | +$1.38M | 0.12% | 186 |
|